University of Florida
HIE Supportive Care Management GuidelinesTable of Contents PagesI.Fluid and Electrolyte Management3 - 6What intravenous fluids should be initiated upon admission to the NICU?What should be the initial intravenous fluids rate?What should be the target glucose value for infants with HIE?What should be the target Magnesium level for infants with HIE?ReferencesII.Feeding Guidelines7 - 9What should be used for feeds?When should feeds be started and at what volume?How quickly should feeds be advanced?References III.Respiratory and Ventilator Management10 - 14What are the goal values for PaCO2 and PaO2 on Arterial Blood Gases (ABGs)?What parameters are recommended for FiO2 and oxygen saturations?What defines a patient who may be a candidate for ECMO?How should temperature correction factor into interpretation of blood gases?Should patients be extubated during the cooling or rewarming process?ReferencesIV.Cardiovascular Support 15 - 20What is the goal Mean Arterial Blood Pressure (MAP) for infants with HIE?What is the optimal method to manage hypotension with HIE?How does hypothermia affect hemodynamic status post asphyxia?When should an echocardiogram be obtain for infants with HIE?Should serum markers of cardiac injury be obtained in infants with HIE, what markers, and when should they be obtained?How should bradycardia associated with hypothermia be managed? References V.Neurologic and Seizure Management 21 - 25What Medications Should Be Used for Analgesia Infants Being Cooled for HIE?II.When and How Should Infants be Monitored for Seizures?How Should Seizures be Managed in Neonates with HIE?Optimal Time for Brain Imaging in Neonates with HIE?ReferencesNetwork StatementThe Florida Neonatal Neurologic Network support the following management guidelines for infants with HIE. We acknowledge a variety of management styles, consensus statements and scientific data exist in this area, however, these guidelines are based on the best available evidence and pooled expert opinions at the time of this document’s creation.-May 2011 I. Fluid and Electrolyte ManagementSection ContentsWhat intravenous fluids should be initiated upon admission to the NICU?What should be the initial intravenous fluids rate?What should be the target glucose value for infants with HIE?What should be the target Magnesium level for infants with HIE?ReferencesI. What intravenous fluids should be initiated upon admission to the NICU?Although no exact literature exists, the most common practice is to start intravenous D10W (10% dextrose solution) upon arrival to the NICU. Recommendations:Use D10W or D10W with protein as the initial intravenous fluid. May consider starting lipids at low concentrations.Add electrolytes as required based on the results of serum electrolytes.May need to increase dextrose concentration to maintain adequate glucose delivery (glucose infusion rate) in light of fluid restriction (see below II).Level of Evidence: V- Expert opinion based on current review of the literature.II. What should be the initial intravenous fluids rate?No randomized trials have been performed to examine the initial rate of fluid therapy and long term outcomes. Current recommendations to limit the consequences of HIE include careful management of fluids, with avoidance of fluid overload and thus avoidance of cerebral edema ADDIN EN.CITE <EndNote><Cite><Author>Kecskes</Author><Year>2005</Year><RecNum>1511</RecNum><record><rec-number>1511</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1511</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kecskes, Z.</author><author>Healy, G.</author><author>Jensen, A.</author></authors></contributors><titles><title>Fluid restriction for term infants with hypoxic-ischaemic encephalopathy following perinatal asphyxia</title><secondary-title>Cochrane Database Syst Rev</secondary-title></titles><periodical><full-title>Cochrane Database Syst Rev</full-title></periodical><pages>CD004337</pages><number>3</number><edition>2005/07/22</edition><keywords><keyword>Asphyxia Neonatorum/*complications</keyword><keyword>Brain Edema/prevention & control</keyword><keyword>*Fluid Therapy</keyword><keyword>Humans</keyword><keyword>Hypoxia-Ischemia, Brain/etiology/*therapy</keyword><keyword>Infant, Newborn</keyword></keywords><dates><year>2005</year></dates><isbn>1469-493X (Electronic)
1361-6137 (Linking)</isbn><accession-num>16034927</accession-num><urls><related-urls><url>;(1). Recommendations for fluid restriction in neonates are based on the experience of restricting fluid intake in adults or older children ADDIN EN.CITE <EndNote><Cite><Author>Kecskes</Author><Year>2005</Year><RecNum>1511</RecNum><record><rec-number>1511</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1511</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kecskes, Z.</author><author>Healy, G.</author><author>Jensen, A.</author></authors></contributors><titles><title>Fluid restriction for term infants with hypoxic-ischaemic encephalopathy following perinatal asphyxia</title><secondary-title>Cochrane Database Syst Rev</secondary-title></titles><periodical><full-title>Cochrane Database Syst Rev</full-title></periodical><pages>CD004337</pages><number>3</number><edition>2005/07/22</edition><keywords><keyword>Asphyxia Neonatorum/*complications</keyword><keyword>Brain Edema/prevention & control</keyword><keyword>*Fluid Therapy</keyword><keyword>Humans</keyword><keyword>Hypoxia-Ischemia, Brain/etiology/*therapy</keyword><keyword>Infant, Newborn</keyword></keywords><dates><year>2005</year></dates><isbn>1469-493X (Electronic)
1361-6137 (Linking)</isbn><accession-num>16034927</accession-num><urls><related-urls><url>;(1). Recommendations: Suggested starting rate of 40-60 ml/kg/day which can be adjusted based on the neonates clinical presentation.Fluid management on subsequent days (past day 1) may be adjusted based on urine output, creatinine levels and electrolytes. Children with oliguria, hyponatremia, increasing creatinine levels, or severe HIE should continue to be restricted to the lower range of total fluid volume intake. In milder cases of HIE, with limited multi-organ system involvement, fluid volumes may be liberalized in an attempt to improve nutrition. Level of Evidence: IIIA- Systematic review and Expert opinion based on current review of the literature.III. What should be the target glucose value for infants with HIE?Under normal conditions, the human brain relies almost entirely on glucose to provide substrate for metabolism ADDIN EN.CITE <EndNote><Cite><Author>McGowan</Author><Year>2006</Year><RecNum>1512</RecNum><record><rec-number>1512</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1512</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McGowan, J. E.</author><author>Perlman, J. M.</author></authors></contributors><auth-address>Division of Neonatology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. jmcgowan@jhmi.edu</auth-address><titles><title>Glucose management during and after intensive delivery room resuscitation</title><secondary-title>Clin Perinatol</secondary-title></titles><periodical><full-title>Clin Perinatol</full-title></periodical><pages>183-96, x</pages><volume>33</volume><number>1</number><edition>2006/03/15</edition><keywords><keyword>Animals</keyword><keyword>Asphyxia Neonatorum/complications/*therapy</keyword><keyword>Delivery Rooms</keyword><keyword>Glucose/pharmacology/therapeutic use</keyword><keyword>Humans</keyword><keyword>Hyperglycemia/*complications</keyword><keyword>Hypoglycemia/*complications/drug therapy</keyword><keyword>Hypoxia-Ischemia, Brain/*etiology/prevention & control</keyword><keyword>Infant, Newborn</keyword><keyword>*Resuscitation</keyword><keyword>Sweetening Agents/pharmacology/therapeutic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0095-5108 (Print)
0095-5108 (Linking)</isbn><accession-num>16533644</accession-num><urls><related-urls><url>(05)00120-X [pii]
10.1016/j.clp.2005.11.007</electronic-resource-num><language>eng</language></record></Cite></EndNote>(2). In newborn infants, cerebral glucose use may account for 70% of total glucose consumption ADDIN EN.CITE <EndNote><Cite><Author>McGowan</Author><Year>2006</Year><RecNum>1512</RecNum><record><rec-number>1512</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1512</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McGowan, J. E.</author><author>Perlman, J. M.</author></authors></contributors><auth-address>Division of Neonatology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. jmcgowan@jhmi.edu</auth-address><titles><title>Glucose management during and after intensive delivery room resuscitation</title><secondary-title>Clin Perinatol</secondary-title></titles><periodical><full-title>Clin Perinatol</full-title></periodical><pages>183-96, x</pages><volume>33</volume><number>1</number><edition>2006/03/15</edition><keywords><keyword>Animals</keyword><keyword>Asphyxia Neonatorum/complications/*therapy</keyword><keyword>Delivery Rooms</keyword><keyword>Glucose/pharmacology/therapeutic use</keyword><keyword>Humans</keyword><keyword>Hyperglycemia/*complications</keyword><keyword>Hypoglycemia/*complications/drug therapy</keyword><keyword>Hypoxia-Ischemia, Brain/*etiology/prevention & control</keyword><keyword>Infant, Newborn</keyword><keyword>*Resuscitation</keyword><keyword>Sweetening Agents/pharmacology/therapeutic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0095-5108 (Print)
0095-5108 (Linking)</isbn><accession-num>16533644</accession-num><urls><related-urls><url>(05)00120-X [pii]
10.1016/j.clp.2005.11.007</electronic-resource-num><language>eng</language></record></Cite></EndNote>(2). Although, the newborn brain can use other substrates, such as lactate or ketones, as an energy source, the supply of these alternate substrates are usually unpredictable and may not compensate entirely for a decrease in glucose availability ADDIN EN.CITE <EndNote><Cite><Author>McGowan</Author><Year>2006</Year><RecNum>1512</RecNum><record><rec-number>1512</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1512</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McGowan, J. E.</author><author>Perlman, J. M.</author></authors></contributors><auth-address>Division of Neonatology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. jmcgowan@jhmi.edu</auth-address><titles><title>Glucose management during and after intensive delivery room resuscitation</title><secondary-title>Clin Perinatol</secondary-title></titles><periodical><full-title>Clin Perinatol</full-title></periodical><pages>183-96, x</pages><volume>33</volume><number>1</number><edition>2006/03/15</edition><keywords><keyword>Animals</keyword><keyword>Asphyxia Neonatorum/complications/*therapy</keyword><keyword>Delivery Rooms</keyword><keyword>Glucose/pharmacology/therapeutic use</keyword><keyword>Humans</keyword><keyword>Hyperglycemia/*complications</keyword><keyword>Hypoglycemia/*complications/drug therapy</keyword><keyword>Hypoxia-Ischemia, Brain/*etiology/prevention & control</keyword><keyword>Infant, Newborn</keyword><keyword>*Resuscitation</keyword><keyword>Sweetening Agents/pharmacology/therapeutic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0095-5108 (Print)
0095-5108 (Linking)</isbn><accession-num>16533644</accession-num><urls><related-urls><url>(05)00120-X [pii]
10.1016/j.clp.2005.11.007</electronic-resource-num><language>eng</language></record></Cite></EndNote>(2).Hypoglycemia is the blood glucose concentration at which the glucose supply to the brain is less than the demand for substrate created by the rate of brain energy metabolism. Because this balance cannot easily be measured, the definition of hypoglycemia is based on statistical analysis of blood glucose concentrations measured over the first few days of life in specific neonates ADDIN EN.CITE <EndNote><Cite><Author>McGowan</Author><Year>2006</Year><RecNum>1512</RecNum><record><rec-number>1512</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1512</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McGowan, J. E.</author><author>Perlman, J. M.</author></authors></contributors><auth-address>Division of Neonatology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. jmcgowan@jhmi.edu</auth-address><titles><title>Glucose management during and after intensive delivery room resuscitation</title><secondary-title>Clin Perinatol</secondary-title></titles><periodical><full-title>Clin Perinatol</full-title></periodical><pages>183-96, x</pages><volume>33</volume><number>1</number><edition>2006/03/15</edition><keywords><keyword>Animals</keyword><keyword>Asphyxia Neonatorum/complications/*therapy</keyword><keyword>Delivery Rooms</keyword><keyword>Glucose/pharmacology/therapeutic use</keyword><keyword>Humans</keyword><keyword>Hyperglycemia/*complications</keyword><keyword>Hypoglycemia/*complications/drug therapy</keyword><keyword>Hypoxia-Ischemia, Brain/*etiology/prevention & control</keyword><keyword>Infant, Newborn</keyword><keyword>*Resuscitation</keyword><keyword>Sweetening Agents/pharmacology/therapeutic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0095-5108 (Print)
0095-5108 (Linking)</isbn><accession-num>16533644</accession-num><urls><related-urls><url>(05)00120-X [pii]
10.1016/j.clp.2005.11.007</electronic-resource-num><language>eng</language></record></Cite></EndNote>(2). During asphyxia, anaerobic glycolysis accelerates the use of glycogen stores; as a consequence, hepatic glycogen stores are depleted, and hepatic glucose production rapidly becomes insufficient to meet cerebral metabolic demands ADDIN EN.CITE <EndNote><Cite><Author>McGowan</Author><Year>2006</Year><RecNum>1512</RecNum><record><rec-number>1512</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1512</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McGowan, J. E.</author><author>Perlman, J. M.</author></authors></contributors><auth-address>Division of Neonatology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. jmcgowan@jhmi.edu</auth-address><titles><title>Glucose management during and after intensive delivery room resuscitation</title><secondary-title>Clin Perinatol</secondary-title></titles><periodical><full-title>Clin Perinatol</full-title></periodical><pages>183-96, x</pages><volume>33</volume><number>1</number><edition>2006/03/15</edition><keywords><keyword>Animals</keyword><keyword>Asphyxia Neonatorum/complications/*therapy</keyword><keyword>Delivery Rooms</keyword><keyword>Glucose/pharmacology/therapeutic use</keyword><keyword>Humans</keyword><keyword>Hyperglycemia/*complications</keyword><keyword>Hypoglycemia/*complications/drug therapy</keyword><keyword>Hypoxia-Ischemia, Brain/*etiology/prevention & control</keyword><keyword>Infant, Newborn</keyword><keyword>*Resuscitation</keyword><keyword>Sweetening Agents/pharmacology/therapeutic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0095-5108 (Print)
0095-5108 (Linking)</isbn><accession-num>16533644</accession-num><urls><related-urls><url>(05)00120-X [pii]
10.1016/j.clp.2005.11.007</electronic-resource-num><language>eng</language></record></Cite></EndNote>(2). Perinatal asphyxia also may be associated with hyperinsulinemia, which may impair hepatic glucose production further and contribute to cerebral energy depletion by increasing uptake of glucose by peripheral tissue ADDIN EN.CITE <EndNote><Cite><Author>McGowan</Author><Year>2006</Year><RecNum>1512</RecNum><record><rec-number>1512</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1512</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McGowan, J. E.</author><author>Perlman, J. M.</author></authors></contributors><auth-address>Division of Neonatology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. jmcgowan@jhmi.edu</auth-address><titles><title>Glucose management during and after intensive delivery room resuscitation</title><secondary-title>Clin Perinatol</secondary-title></titles><periodical><full-title>Clin Perinatol</full-title></periodical><pages>183-96, x</pages><volume>33</volume><number>1</number><edition>2006/03/15</edition><keywords><keyword>Animals</keyword><keyword>Asphyxia Neonatorum/complications/*therapy</keyword><keyword>Delivery Rooms</keyword><keyword>Glucose/pharmacology/therapeutic use</keyword><keyword>Humans</keyword><keyword>Hyperglycemia/*complications</keyword><keyword>Hypoglycemia/*complications/drug therapy</keyword><keyword>Hypoxia-Ischemia, Brain/*etiology/prevention & control</keyword><keyword>Infant, Newborn</keyword><keyword>*Resuscitation</keyword><keyword>Sweetening Agents/pharmacology/therapeutic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0095-5108 (Print)
0095-5108 (Linking)</isbn><accession-num>16533644</accession-num><urls><related-urls><url>(05)00120-X [pii]
10.1016/j.clp.2005.11.007</electronic-resource-num><language>eng</language></record></Cite></EndNote>(2). When hypoglycemia is coupled with asphyxia, the cerebral metabolic effects of the latter are magnified ADDIN EN.CITE <EndNote><Cite><Author>Salhab</Author><Year>2004</Year><RecNum>1514</RecNum><record><rec-number>1514</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1514</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Salhab, W. A.</author><author>Wyckoff, M. H.</author><author>Laptook, A. R.</author><author>Perlman, J. M.</author></authors></contributors><auth-address>University of Texas Southwestern Medical Center at Dallas, Department of Pediatrics, Neonatal-Perinatal Medicine, Dallas, Texas, USA.</auth-address><titles><title>Initial hypoglycemia and neonatal brain injury in term infants with severe fetal acidemia</title><secondary-title>Pediatrics</secondary-title></titles><periodical><full-title>Pediatrics</full-title></periodical><pages>361-6</pages><volume>114</volume><number>2</number><edition>2004/08/03</edition><keywords><keyword>Acidosis/*complications</keyword><keyword>Birth Weight</keyword><keyword>Gestational Age</keyword><keyword>Humans</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Hypoglycemia/*complications</keyword><keyword>Hypoxia-Ischemia, Brain/*etiology</keyword><keyword>Infant, Newborn</keyword><keyword>Logistic Models</keyword><keyword>Multivariate Analysis</keyword><keyword>Retrospective Studies</keyword><keyword>Seizures/*etiology</keyword></keywords><dates><year>2004</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1098-4275 (Electronic)
0031-4005 (Linking)</isbn><accession-num>15286217</accession-num><urls><related-urls><url> [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>(3). In addition, hypoglycemia has been associated with impairment in cerebral autoregulation ADDIN EN.CITE <EndNote><Cite><Author>Salhab</Author><Year>2004</Year><RecNum>1514</RecNum><record><rec-number>1514</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1514</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Salhab, W. A.</author><author>Wyckoff, M. H.</author><author>Laptook, A. R.</author><author>Perlman, J. M.</author></authors></contributors><auth-address>University of Texas Southwestern Medical Center at Dallas, Department of Pediatrics, Neonatal-Perinatal Medicine, Dallas, Texas, USA.</auth-address><titles><title>Initial hypoglycemia and neonatal brain injury in term infants with severe fetal acidemia</title><secondary-title>Pediatrics</secondary-title></titles><periodical><full-title>Pediatrics</full-title></periodical><pages>361-6</pages><volume>114</volume><number>2</number><edition>2004/08/03</edition><keywords><keyword>Acidosis/*complications</keyword><keyword>Birth Weight</keyword><keyword>Gestational Age</keyword><keyword>Humans</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Hypoglycemia/*complications</keyword><keyword>Hypoxia-Ischemia, Brain/*etiology</keyword><keyword>Infant, Newborn</keyword><keyword>Logistic Models</keyword><keyword>Multivariate Analysis</keyword><keyword>Retrospective Studies</keyword><keyword>Seizures/*etiology</keyword></keywords><dates><year>2004</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1098-4275 (Electronic)
0031-4005 (Linking)</isbn><accession-num>15286217</accession-num><urls><related-urls><url> [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>(3). The use of glucose as a therapy for HIE in animal models have shown conflicting results PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NY0dvd2FuPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48
UmVjTnVtPjE1MTI8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE1MTI8L3JlYy1udW1iZXI+
PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSIwdnd3dzJ2dGpmMmRmMWV4ZXBhdng1
NXRzZjJkd2V4dmV2emQiPjE1MTI8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0i
Sm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0
aG9yPk1jR293YW4sIEouIEUuPC9hdXRob3I+PGF1dGhvcj5QZXJsbWFuLCBKLiBNLjwvYXV0aG9y
PjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRpdmlzaW9uIG9mIE5lb25h
dG9sb2d5LCBUaGUgSm9obnMgSG9wa2lucyBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwg
QmFsdGltb3JlLCBNRCAyMTI4NywgVVNBLiBqbWNnb3dhbkBqaG1pLmVkdTwvYXV0aC1hZGRyZXNz
Pjx0aXRsZXM+PHRpdGxlPkdsdWNvc2UgbWFuYWdlbWVudCBkdXJpbmcgYW5kIGFmdGVyIGludGVu
c2l2ZSBkZWxpdmVyeSByb29tIHJlc3VzY2l0YXRpb248L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+
Q2xpbiBQZXJpbmF0b2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVs
bC10aXRsZT5DbGluIFBlcmluYXRvbDwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjE4
My05NiwgeDwvcGFnZXM+PHZvbHVtZT4zMzwvdm9sdW1lPjxudW1iZXI+MTwvbnVtYmVyPjxlZGl0
aW9uPjIwMDYvMDMvMTU8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFuaW1hbHM8L2tleXdv
cmQ+PGtleXdvcmQ+QXNwaHl4aWEgTmVvbmF0b3J1bS9jb21wbGljYXRpb25zLyp0aGVyYXB5PC9r
ZXl3b3JkPjxrZXl3b3JkPkRlbGl2ZXJ5IFJvb21zPC9rZXl3b3JkPjxrZXl3b3JkPkdsdWNvc2Uv
cGhhcm1hY29sb2d5L3RoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tl
eXdvcmQ+PGtleXdvcmQ+SHlwZXJnbHljZW1pYS8qY29tcGxpY2F0aW9uczwva2V5d29yZD48a2V5
d29yZD5IeXBvZ2x5Y2VtaWEvKmNvbXBsaWNhdGlvbnMvZHJ1ZyB0aGVyYXB5PC9rZXl3b3JkPjxr
ZXl3b3JkPkh5cG94aWEtSXNjaGVtaWEsIEJyYWluLypldGlvbG9neS9wcmV2ZW50aW9uICZhbXA7
IGNvbnRyb2w8L2tleXdvcmQ+PGtleXdvcmQ+SW5mYW50LCBOZXdib3JuPC9rZXl3b3JkPjxrZXl3
b3JkPipSZXN1c2NpdGF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPlN3ZWV0ZW5pbmcgQWdlbnRzL3Bo
YXJtYWNvbG9neS90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHll
YXI+MjAwNjwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1hcjwvZGF0ZT48L3B1Yi1kYXRlcz48L2Rh
dGVzPjxpc2JuPjAwOTUtNTEwOCAoUHJpbnQpJiN4RDswMDk1LTUxMDggKExpbmtpbmcpPC9pc2Ju
PjxhY2Nlc3Npb24tbnVtPjE2NTMzNjQ0PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy
bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21k
PVJldHJpZXZlJmFtcDtkYj1QdWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0x
NjUzMzY0NDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1u
dW0+UzAwOTUtNTEwOCgwNSkwMDEyMC1YIFtwaWldJiN4RDsxMC4xMDE2L2ouY2xwLjIwMDUuMTEu
MDA3PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3Jl
Y29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5TYWxoYWI8L0F1dGhvcj48WWVhcj4yMDA0PC9ZZWFy
PjxSZWNOdW0+MTUxNDwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTUxNDwvcmVjLW51bWJl
cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjB2d3d3MnZ0amYyZGYxZXhlcGF2
eDU1dHNmMmR3ZXh2ZXZ6ZCI+MTUxNDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1l
PSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxh
dXRob3I+U2FsaGFiLCBXLiBBLjwvYXV0aG9yPjxhdXRob3I+V3lja29mZiwgTS4gSC48L2F1dGhv
cj48YXV0aG9yPkxhcHRvb2ssIEEuIFIuPC9hdXRob3I+PGF1dGhvcj5QZXJsbWFuLCBKLiBNLjwv
YXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlVuaXZlcnNpdHkg
b2YgVGV4YXMgU291dGh3ZXN0ZXJuIE1lZGljYWwgQ2VudGVyIGF0IERhbGxhcywgRGVwYXJ0bWVu
dCBvZiBQZWRpYXRyaWNzLCBOZW9uYXRhbC1QZXJpbmF0YWwgTWVkaWNpbmUsIERhbGxhcywgVGV4
YXMsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Jbml0aWFsIGh5cG9nbHljZW1p
YSBhbmQgbmVvbmF0YWwgYnJhaW4gaW5qdXJ5IGluIHRlcm0gaW5mYW50cyB3aXRoIHNldmVyZSBm
ZXRhbCBhY2lkZW1pYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5QZWRpYXRyaWNzPC9zZWNvbmRh
cnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+UGVkaWF0cmljczwvZnVs
bC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjM2MS02PC9wYWdlcz48dm9sdW1lPjExNDwvdm9s
dW1lPjxudW1iZXI+MjwvbnVtYmVyPjxlZGl0aW9uPjIwMDQvMDgvMDM8L2VkaXRpb24+PGtleXdv
cmRzPjxrZXl3b3JkPkFjaWRvc2lzLypjb21wbGljYXRpb25zPC9rZXl3b3JkPjxrZXl3b3JkPkJp
cnRoIFdlaWdodDwva2V5d29yZD48a2V5d29yZD5HZXN0YXRpb25hbCBBZ2U8L2tleXdvcmQ+PGtl
eXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5ZHJvZ2VuLUlvbiBDb25jZW50cmF0aW9u
PC9rZXl3b3JkPjxrZXl3b3JkPkh5cG9nbHljZW1pYS8qY29tcGxpY2F0aW9uczwva2V5d29yZD48
a2V5d29yZD5IeXBveGlhLUlzY2hlbWlhLCBCcmFpbi8qZXRpb2xvZ3k8L2tleXdvcmQ+PGtleXdv
cmQ+SW5mYW50LCBOZXdib3JuPC9rZXl3b3JkPjxrZXl3b3JkPkxvZ2lzdGljIE1vZGVsczwva2V5
d29yZD48a2V5d29yZD5NdWx0aXZhcmlhdGUgQW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+UmV0
cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlNlaXp1cmVzLypldGlvbG9neTwv
a2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA0PC95ZWFyPjxwdWItZGF0ZXM+PGRh
dGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTA5OC00Mjc1IChFbGVjdHJv
bmljKSYjeEQ7MDAzMS00MDA1IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xNTI4NjIx
NzwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2Jp
Lm5sbS5uaWguZ292L2VudHJlei9xdWVyeS5mY2dpP2NtZD1SZXRyaWV2ZSZhbXA7ZGI9UHViTWVk
JmFtcDtkb3B0PUNpdGF0aW9uJmFtcDtsaXN0X3VpZHM9MTUyODYyMTc8L3VybD48L3JlbGF0ZWQt
dXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjExNC8yLzM2MSBbcGlpXTwvZWxl
Y3Ryb25pYy1yZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9D
aXRlPjwvRW5kTm90ZT4AYQA1
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NY0dvd2FuPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48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ADDIN EN.CITE.DATA (2, 3). Human clinical observations have demonstrated a correlation between lower levels of serum glucose concentrations and higher Sarnat scores ADDIN EN.CITE <EndNote><Cite><Author>Basu</Author><Year>2009</Year><RecNum>1515</RecNum><record><rec-number>1515</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1515</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Basu, P.</author><author>Som, S.</author><author>Choudhuri, N.</author><author>Das, H.</author></authors></contributors><auth-address>Department of Biochemistry, Burdwan Medical College and Hospital, Burdwan, West Bengal, India. dr.pallab_basu@</auth-address><titles><title>Contribution of the blood glucose level in perinatal asphyxia</title><secondary-title>Eur J Pediatr</secondary-title></titles><periodical><full-title>Eur J Pediatr</full-title></periodical><pages>833-8</pages><volume>168</volume><number>7</number><edition>2008/10/10</edition><keywords><keyword>*Apgar Score</keyword><keyword>Asphyxia Neonatorum/blood/complications/*physiopathology</keyword><keyword>Female</keyword><keyword>Glucose/*metabolism</keyword><keyword>Hospitals</keyword><keyword>Humans</keyword><keyword>Hypoxia-Ischemia, Brain/blood/etiology/*physiopathology</keyword><keyword>Infant, Newborn</keyword><keyword>Linear Models</keyword><keyword>Male</keyword><keyword>Prospective Studies</keyword><keyword>Risk Factors</keyword><keyword>Severity of Illness Index</keyword><keyword>Uric Acid/*blood</keyword></keywords><dates><year>2009</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1432-1076 (Electronic)
0340-6199 (Linking)</isbn><accession-num>18843505</accession-num><urls><related-urls><url>;(4). Further, initial hypoglycemia (≤40) is an important risk factor for perinatal brain injury in depressed neonates ADDIN EN.CITE <EndNote><Cite><Author>Salhab</Author><Year>2004</Year><RecNum>1514</RecNum><record><rec-number>1514</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1514</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Salhab, W. A.</author><author>Wyckoff, M. H.</author><author>Laptook, A. R.</author><author>Perlman, J. M.</author></authors></contributors><auth-address>University of Texas Southwestern Medical Center at Dallas, Department of Pediatrics, Neonatal-Perinatal Medicine, Dallas, Texas, USA.</auth-address><titles><title>Initial hypoglycemia and neonatal brain injury in term infants with severe fetal acidemia</title><secondary-title>Pediatrics</secondary-title></titles><periodical><full-title>Pediatrics</full-title></periodical><pages>361-6</pages><volume>114</volume><number>2</number><edition>2004/08/03</edition><keywords><keyword>Acidosis/*complications</keyword><keyword>Birth Weight</keyword><keyword>Gestational Age</keyword><keyword>Humans</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Hypoglycemia/*complications</keyword><keyword>Hypoxia-Ischemia, Brain/*etiology</keyword><keyword>Infant, Newborn</keyword><keyword>Logistic Models</keyword><keyword>Multivariate Analysis</keyword><keyword>Retrospective Studies</keyword><keyword>Seizures/*etiology</keyword></keywords><dates><year>2004</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1098-4275 (Electronic)
0031-4005 (Linking)</isbn><accession-num>15286217</accession-num><urls><related-urls><url> [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>(3).For infants with hyperinsulinism such as infant of diabetic mothers, an operational threshold of 60mg/dl is appropriate for defining the lower limit of normal, as these neonates have very low levels of alternative fuels such as ketones and lactate at low blood glucose concentrations ADDIN EN.CITE <EndNote><Cite><Author>Deshpande</Author><Year>2005</Year><RecNum>1516</RecNum><record><rec-number>1516</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1516</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Deshpande, S.</author><author>Ward Platt, M.</author></authors></contributors><auth-address>Royal Shrewsbury Hospital, Mytton Oak Road, Shrewsbury, SY2 6SP, UK. deshpande@rsh.nhs.uk</auth-address><titles><title>The investigation and management of neonatal hypoglycaemia</title><secondary-title>Semin Fetal Neonatal Med</secondary-title></titles><periodical><full-title>Semin Fetal Neonatal Med</full-title></periodical><pages>351-61</pages><volume>10</volume><number>4</number><edition>2005/06/01</edition><keywords><keyword>Blood Glucose/analysis</keyword><keyword>Female</keyword><keyword>Glucose/*metabolism</keyword><keyword>Humans</keyword><keyword>Hyperinsulinism/diagnosis</keyword><keyword>Hypoglycemia/*diagnosis/prevention & control/*therapy</keyword><keyword>Infant, Newborn/*metabolism</keyword><keyword>Infant, Small for Gestational Age/metabolism</keyword><keyword>Neonatal Screening/*methods</keyword><keyword>Pregnancy</keyword><keyword>Risk Assessment</keyword></keywords><dates><year>2005</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1744-165X (Print)
1744-165X (Linking)</isbn><accession-num>15922680</accession-num><urls><related-urls><url>(05)00019-3 [pii]
10.1016/j.siny.2005.04.002</electronic-resource-num><language>eng</language></record></Cite></EndNote>(5). Since HIE may be associated with hyperinsulinism, an ideal target of 60-70 mg/dl may be beneficial. Recommendations: Screen for hypoglycemia as early as possible.The target glucose range should be at least above 40mg/dl with an ideal target of 60-70mg/dl or higher.Avoid marked hyperglycemia (≥150 mg/dl). Level of Evidence: IV- Case Series and Expert opinion based on current review of the literature.IV. What should be the target Magnesium level for infants with HIE?Post asphyxia, during the secondary energy failure phase of HIE, there is an excessive release of glutamate which in turn opens NMDA channels within the brain. These open channels allow for excessive calcium influx into neurons which may result in sustained neuronal injury ADDIN EN.CITE <EndNote><Cite><Author>Choi</Author><Year>1993</Year><RecNum>1517</RecNum><record><rec-number>1517</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1517</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Choi, D. W.</author><author>Hartley, D. M.</author></authors></contributors><auth-address>Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110.</auth-address><titles><title>Calcium and glutamate-induced cortical neuronal death</title><secondary-title>Res Publ Assoc Res Nerv Ment Dis</secondary-title></titles><periodical><full-title>Res Publ Assoc Res Nerv Ment Dis</full-title></periodical><pages>23-34</pages><volume>71</volume><edition>1993/01/01</edition><keywords><keyword>Animals</keyword><keyword>Calcium/*metabolism/pharmacology</keyword><keyword>Cell Death/*drug effects</keyword><keyword>Cerebral Cortex/cytology/*drug effects/physiology</keyword><keyword>Glutamates/*toxicity</keyword><keyword>Glutamic Acid</keyword><keyword>Models, Neurological</keyword><keyword>N-Methylaspartate/antagonists & inhibitors</keyword><keyword>Neurons/cytology/*drug effects/physiology</keyword><keyword>Neurotoxins/*toxicity</keyword><keyword>Receptors, Glutamate/drug effects/physiology</keyword><keyword>Receptors, N-Methyl-D-Aspartate/drug effects/physiology</keyword><keyword>Receptors, Neurotransmitter/drug effects/physiology</keyword></keywords><dates><year>1993</year></dates><isbn>0091-7443 (Print)
0091-7443 (Linking)</isbn><accession-num>8093332</accession-num><urls><related-urls><url>;(6). Magnesium (Mg2+) is a known NMDA receptor antagonist which may block this calcium influx thereby reducing cortical damage ADDIN EN.CITE <EndNote><Cite><Author>Nowak</Author><Year>1984</Year><RecNum>1518</RecNum><record><rec-number>1518</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1518</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nowak, L.</author><author>Bregestovski, P.</author><author>Ascher, P.</author><author>Herbet, A.</author><author>Prochiantz, A.</author></authors></contributors><titles><title>Magnesium gates glutamate-activated channels in mouse central neurones</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title></periodical><pages>462-5</pages><volume>307</volume><number>5950</number><edition>1984/02/02</edition><keywords><keyword>Animals</keyword><keyword>Aspartic Acid/analogs & derivatives/metabolism</keyword><keyword>Brain/embryology/*physiology</keyword><keyword>Cells, Cultured</keyword><keyword>Electric Conductivity</keyword><keyword>Glutamates/*physiology</keyword><keyword>Ion Channels/*physiology</keyword><keyword>Kinetics</keyword><keyword>Magnesium/*physiology</keyword><keyword>Membrane Potentials</keyword><keyword>Mice</keyword><keyword>N-Methylaspartate</keyword></keywords><dates><year>1984</year><pub-dates><date>Feb 2-8</date></pub-dates></dates><isbn>0028-0836 (Print)
0028-0836 (Linking)</isbn><accession-num>6320006</accession-num><urls><related-urls><url>;(7). The evidence for the use of Mg2+ as a neuroprotective agent in both animal models of HIE and human trials are inconclusive ADDIN EN.CITE <EndNote><Cite><Author>Bhat</Author><Year>2009</Year><RecNum>1519</RecNum><record><rec-number>1519</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1519</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bhat, M. A.</author><author>Charoo, B. A.</author><author>Bhat, J. I.</author><author>Ahmad, S. M.</author><author>Ali, S. W.</author><author>Mufti, M. U.</author></authors></contributors><auth-address>Department of Pediatrics, SKISrinagar, Kashmir, India 190011. mbhat47@</auth-address><titles><title>Magnesium sulfate in severe perinatal asphyxia: a randomized, placebo-controlled trial</title><secondary-title>Pediatrics</secondary-title></titles><periodical><full-title>Pediatrics</full-title></periodical><pages>e764-9</pages><volume>123</volume><number>5</number><edition>2009/04/08</edition><keywords><keyword>Asphyxia Neonatorum/blood/complications/*drug therapy/physiopathology</keyword><keyword>Brain Diseases/etiology</keyword><keyword>Calcium Channel Blockers/*therapeutic use</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Infant, Newborn</keyword><keyword>Magnesium/blood</keyword><keyword>Magnesium Sulfate/*therapeutic use</keyword><keyword>Male</keyword><keyword>Neurologic Examination</keyword><keyword>Neuroprotective Agents/therapeutic use</keyword><keyword>Prospective Studies</keyword></keywords><dates><year>2009</year><pub-dates><date>May</date></pub-dates></dates><isbn>1098-4275 (Electronic)
0031-4005 (Linking)</isbn><accession-num>19349375</accession-num><urls><related-urls><url> [pii]
10.1542/peds.2007-3642</electronic-resource-num><language>eng</language></record></Cite></EndNote>(8). However, there are several human study that support the infusion of Mg2+ sulfate post asphyxia to improve short-term neurodevelopmental outcome with no major adverse events associate with the infusion PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CaGF0PC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48UmVj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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CaGF0PC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48UmVj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ADDIN EN.CITE.DATA (8-10). In the above referenced studies, mean Mg+2 serum concentrations were ≥ 2.15 mg/dL (1.2 mmol/L) for the treatment groups. Of note, normal term neonatal mean reference Mg2+ levels over the first five days of life are 1.92 mg/dL +/- 0.27 ADDIN EN.CITE <EndNote><Cite><Author>Constantine</Author><Year>1964</Year><RecNum>1520</RecNum><record><rec-number>1520</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1520</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Constantine, S</author></authors></contributors><titles><title>Serum Magnesium Levels in the Newborn</title><secondary-title>Pediatrics</secondary-title></titles><periodical><full-title>Pediatrics</full-title></periodical><pages>696-974</pages><volume>33</volume><dates><year>1964</year><pub-dates><date>1964</date></pub-dates></dates><urls></urls></record></Cite></EndNote>(11). Recommendations:1. Obtain Mg2+ level with the first set of electrolytes and then at least every 24 hours until stable.2. Maintain Mg2+ level within the normal range (1.7 to 2.2 mg/dL). 3. If Mg2+ level is < 1.7 mg/dL may infuse Mg2+Sulfate (25-50 mg/kg/dose) over 1-2 hours. Level of Evidence: IV- Case Series and Expert opinion based on current review of the literature.V. References ADDIN EN.REFLIST 1.Kecskes Z, Healy G, Jensen A. Fluid restriction for term infants with hypoxic-ischaemic encephalopathy following perinatal asphyxia. Cochrane Database Syst Rev 2005(3):CD004337.2.McGowan JE, Perlman JM. Glucose management during and after intensive delivery room resuscitation. Clin Perinatol 2006;33(1):183-96, x.3.Salhab WA, Wyckoff MH, Laptook AR, Perlman JM. Initial hypoglycemia and neonatal brain injury in term infants with severe fetal acidemia. Pediatrics 2004;114(2):361-6.4.Basu P, Som S, Choudhuri N, Das H. Contribution of the blood glucose level in perinatal asphyxia. Eur J Pediatr 2009;168(7):833-8.5.Deshpande S, Ward Platt M. The investigation and management of neonatal hypoglycaemia. Semin Fetal Neonatal Med 2005;10(4):351-61.6.Choi DW, Hartley DM. Calcium and glutamate-induced cortical neuronal death. Res Publ Assoc Res Nerv Ment Dis 1993;71:23-34.7.Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984;307(5950):462-5.8.Bhat MA, Charoo BA, Bhat JI, Ahmad SM, Ali SW, Mufti MU. Magnesium sulfate in severe perinatal asphyxia: a randomized, placebo-controlled trial. Pediatrics 2009;123(5):e764-9.9.Ichiba H, Tamai H, Negishi H, Ueda T, Kim TJ, Sumida Y, et al. Randomized controlled trial of magnesium sulfate infusion for severe birth asphyxia. Pediatr Int 2002;44(5):505-9.10.Ichiba H, Yokoi T, Tamai H, Ueda T, Kim TJ, Yamano T. Neurodevelopmental outcome of infants with birth asphyxia treated with magnesium sulfate. Pediatr Int 2006;48(1):70-5.11.Constantine S. Serum Magnesium Levels in the Newborn. Pediatrics 1964;33:696-974.II. Feeding Guidelines for Neonates with HIESection ContentsWhat should be used for feeds?When should feeds be started and at what volume?How quickly should feeds be advanced?References I. What should be used for feeds?Feeding should be started with breast milk if available. Although there is no evidence to directly support the claim that breast milk is better than formula for improving the outcome of neonates with HIE, evidence has shown that breast milk may improve cognitive abilities in term neonates ADDIN EN.CITE <EndNote><Cite><Author>Kramer</Author><RecNum>1449</RecNum><record><rec-number>1449</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1449</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kramer, M. S.</author></authors></contributors><auth-address>Department of Pediatrics, McGill University, Canada. michael.kramer@mcgill.ca</auth-address><titles><title>"Breast is best": The evidence</title><secondary-title>Early Hum Dev</secondary-title></titles><periodical><full-title>Early Hum Dev</full-title></periodical><pages>729-32</pages><volume>86</volume><number>11</number><edition>2010/09/18</edition><dates><pub-dates><date>Nov</date></pub-dates></dates><isbn>1872-6232 (Electronic)
0378-3782 (Linking)</isbn><accession-num>20846797</accession-num><urls><related-urls><url>(10)00207-0 [pii]
10.1016/j.earlhumdev.2010.08.005</electronic-resource-num><language>eng</language></record></Cite></EndNote>(1). Although born at or near term, neonates who have suffered from HIE are at higher risk of developing necrotizing enterocolitis (NEC). Studies have demonstrated that breast milk feeding is associated with a lower incidence of NEC PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MZSBIdWVyb3UtTHVyb248L0F1dGhvcj48UmVjTnVtPjE0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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MZSBIdWVyb3UtTHVyb248L0F1dGhvcj48UmVjTnVtPjE0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ADDIN EN.CITE.DATA (2). In addition, breast milk is a rich source of multipotent mesenchymal stem cells ADDIN EN.CITE <EndNote><Cite><Author>Patki</Author><RecNum>1451</RecNum><record><rec-number>1451</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1451</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Patki, S.</author><author>Kadam, S.</author><author>Chandra, V.</author><author>Bhonde, R.</author></authors></contributors><auth-address>Patki Research Foundation and Hospital, Shahupuri, Kolhapur, India.</auth-address><titles><title>Human breast milk is a rich source of multipotent mesenchymal stem cells</title><secondary-title>Hum Cell</secondary-title></titles><periodical><full-title>Hum Cell</full-title></periodical><pages>35-40</pages><volume>23</volume><number>2</number><edition>2010/08/18</edition><dates><pub-dates><date>May</date></pub-dates></dates><isbn>1749-0774 (Electronic)
0914-7470 (Linking)</isbn><accession-num>20712706</accession-num><urls><related-urls><url> [pii]
10.1111/j.1749-0774.2010.00083.x</electronic-resource-num><language>eng</language></record></Cite></EndNote>(3). Recommendations:1. Feed with breast milk if available and no contraindications exist (AAP policy).2. May use formula if breast milk is not available.Level of Evidence: IV- Case Series and Expert opinion based on current review of the literature.II. When should feeds be started and at what volume?Recent studies have demonstrated NEC to occur from 9-15 days of age in term neonates with HIE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MYW1iZXJ0PC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MYW1iZXJ0PC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48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ADDIN EN.CITE.DATA (4, 5). Many of the risk factors present in term neonates for developing NEC, such as hypotension, may be present in neonates with HIE after the initial insult ADDIN EN.CITE <EndNote><Cite><Author>Lambert</Author><Year>2007</Year><RecNum>1502</RecNum><record><rec-number>1502</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1502</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lambert, D. K.</author><author>Christensen, R. D.</author><author>Henry, E.</author><author>Besner, G. E.</author><author>Baer, V. L.</author><author>Wiedmeier, S. E.</author><author>Stoddard, R. A.</author><author>Miner, C. A.</author><author>Burnett, J.</author></authors></contributors><auth-address>Intermountain Health Care, Ogden, UT 84403, USA. rdchris4@</auth-address><titles><title>Necrotizing enterocolitis in term neonates: data from a multihospital health-care system</title><secondary-title>J Perinatol</secondary-title></titles><periodical><full-title>J Perinatol</full-title></periodical><pages>437-43</pages><volume>27</volume><number>7</number><edition>2007/03/30</edition><keywords><keyword>Databases, Factual</keyword><keyword>Enterocolitis, Necrotizing/*epidemiology/etiology/prevention & control</keyword><keyword>Health Maintenance Organizations</keyword><keyword>Humans</keyword><keyword>Infant Nutritional Physiological Phenomena</keyword><keyword>Infant, Newborn</keyword><keyword>Intensive Care Units, Neonatal</keyword><keyword>Medical Records</keyword><keyword>*Milk, Human</keyword><keyword>Retrospective Studies</keyword><keyword>Utah/epidemiology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0743-8346 (Print)
0743-8346 (Linking)</isbn><accession-num>17392837</accession-num><urls><related-urls><url> [pii]
10.1038/sj.jp.7211738</electronic-resource-num><language>eng</language></record></Cite></EndNote>(4). Further, the effect of hypothermia on feeding tolerance in this population is currently unknown. In addition, studies have illustrated that intestinal motility in neonates with HIE is abnormal at 7 days post insult ADDIN EN.CITE <EndNote><Cite><Author>Berseth</Author><Year>1992</Year><RecNum>1504</RecNum><record><rec-number>1504</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1504</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Berseth, C. L.</author><author>McCoy, H. H.</author></authors></contributors><auth-address>Department of Pediatrics, Mayo Clinic, Rochester, MN.</auth-address><titles><title>Birth asphyxia alters neonatal intestinal motility in term neonates</title><secondary-title>Pediatrics</secondary-title></titles><periodical><full-title>Pediatrics</full-title></periodical><pages>669-73</pages><volume>90</volume><number>5</number><edition>1992/11/01</edition><keywords><keyword>Asphyxia Neonatorum/*physiopathology</keyword><keyword>*Enteral Nutrition</keyword><keyword>*Gastrointestinal Motility</keyword><keyword>Humans</keyword><keyword>Infant, Newborn/*physiology</keyword><keyword>Manometry</keyword></keywords><dates><year>1992</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0031-4005 (Print)
0031-4005 (Linking)</isbn><accession-num>1408536</accession-num><urls><related-urls><url>;(6). Recommendations: Feeding may be started as early as deemed appropriate by the clinical team. This may be with small amounts during hypothermia in neonates without hypotension or the need for pressor support. Level of Evidence: V- Expert opinion based on current review of the literature.III. How quickly should feeds be advanced?There is no evidence for term neonates who have suffered from HIE to guide the advancement of feeds. Therefore, one may extrapolate the experience and rationale used for preterm neonates ADDIN EN.CITE <EndNote><Cite><Author>Tyson</Author><Year>2007</Year><RecNum>1505</RecNum><record><rec-number>1505</rec-number><foreign-keys><key app="EN" db-id="0vwww2vtjf2df1exepavx55tsf2dwexvevzd">1505</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tyson, J. E.</author><author>Kennedy, K. A.</author><author>Lucke, J. F.</author><author>Pedroza, C.</author></authors></contributors><auth-address>The University of Texas Medical School at Houston, Houston, TX 77030, USA. jon.e.tyson@uth.tmc.edu</auth-address><titles><title>Dilemmas initiating enteral feedings in high risk infants: how can they be resolved?</title><secondary-title>Semin Perinatol</secondary-title></titles><periodical><full-title>Semin Perinatol</full-title></periodical><pages>61-73</pages><volume>31</volume><number>2</number><edition>2007/04/28</edition><keywords><keyword>Bayes Theorem</keyword><keyword>Enteral Nutrition/*adverse effects</keyword><keyword>Enterocolitis, Necrotizing/prevention & control</keyword><keyword>Humans</keyword><keyword>Infant Nutritional Physiological Phenomena/*physiology</keyword><keyword>Infant, Newborn</keyword><keyword>Infant, Very Low Birth Weight/*growth & development/physiology</keyword><keyword>*Randomized Controlled Trials as Topic/methods</keyword><keyword>Risk Factors</keyword><keyword>Safety</keyword><keyword>Sample Size</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0146-0005 (Print)
0146-0005 (Linking)</isbn><accession-num>17462490</accession-num><urls><related-urls><url>(07)00030-4 [pii]
10.1053/j.semperi.2007.02.008</electronic-resource-num><language>eng</language></record></Cite></EndNote>(7). Route of feeding and type of feed may also be considered in the advancement of feeds. Recommendations: Feeds may be advanced as rapidly as appropriate based on clinical condition and route of feeding. Level of Evidence: V- Expert opinion based on current review of the literature.IV. References ADDIN EN.REFLIST 1.Kramer MS. "Breast is best": The evidence. Early Hum Dev;86(11):729-32.2.Le Huerou-Luron I, Blat S, Boudry G. Breast- v. formula-feeding: impacts on the digestive tract and immediate and long-term health effects. Nutr Res Rev;23(1):23-36.3.Patki S, Kadam S, Chandra V, Bhonde R. Human breast milk is a rich source of multipotent mesenchymal stem cells. Hum Cell;23(2):35-40.4.Lambert DK, Christensen RD, Henry E, Besner GE, Baer VL, Wiedmeier SE, et al. Necrotizing enterocolitis in term neonates: data from a multihospital health-care system. J Perinatol 2007;27(7):437-43.5.Maayan-Metzger A, Itzchak A, Mazkereth R, Kuint J. Necrotizing enterocolitis in full-term infants: case-control study and review of the literature. J Perinatol 2004;24(8):494-9.6.Berseth CL, McCoy HH. Birth asphyxia alters neonatal intestinal motility in term neonates. Pediatrics 1992;90(5):669-73.7.Tyson JE, Kennedy KA, Lucke JF, Pedroza C. Dilemmas initiating enteral feedings in high risk infants: how can they be resolved? Semin Perinatol 2007;31(2):61-73.III. Respiratory and Ventilator ManagementSection ContentsWhat are the goal values for PaCO2 and PaO2 on ABGs?What parameters are recommended for FiO2 and oxygen saturations?What defines a patient who may be a candidate for ECMO?How should temperature correction factor into the interpretation of blood gases?Should patients be extubated during the cooling or rewarming process?What are the recommendations regarding ventilator management?VII. What are the recommendations regarding the use of nitric oxide (iNO)?VIII. References I. What are the goal values for PaCO2 and PaO2 on ABGs?With regard to CO2, the goal may be values within the normal range (40-55 mmHg Note: although higher PaCO2 may be appropriate for certain infants with significant ventilator requirements). Infants who have suffered a hypoxic-ischemic insult will have resultant changes in metabolism that lead to less CO2 production. Also, CO2 may be low secondary to respiratory compensation for the initial metabolic acidosis. Hypothermia may reduce CO2 production as well (1). These factors combined lead to less ventilator support needed to obtain a desirable CO2. Hypocapnia has also been shown to be harmful in this population. Low CO2 leads to decreased cerebral perfusion and decreased oxygen release from hemoglobin. Current research has also determined it to be associated with death and poor neurodevelopmental outcome in infants with HIE (2). Hyperoxia has also been shown to have a detrimental effect on these infants. Hyperoxia leads to increased oxidative stress and increased free radical production. It can be especially toxic in the setting of reperfusion and attenuate brain injury (3). Further, hyperoxia has been associated with death and poor long-term outcomes post asphyxia (2). We therefore recommend goal PaO2 values of 50-100 mmHg. Infants who suffer from birth depression and resultant HIE often undergo vigorous resuscitation at birth. As a result, they may have hyperoxia and hypocapnia from birth. After initial asphyxia the cardiopulmonary function often improves rapidly necessitating less support. We recommend obtaining a post resuscitation ABG, and using a conservative ventilator strategy. Recommendations:Keep PaCO2 in the range of 40-55 mmHg (Note: these are suggested ranges and may need to be modified for individual patient care based on the bedside clinicians exam and the patient’s underlying pathophysiology). If the neonate is self hyperventilating to a lower level, assure that mechanical ventilation is not contributing to further decreases in CO2 by lowering support as much as clinically indicated.Keep PaO2 in the range of 50-100 mmHg to prevent hyperoxic injury.Avoid over ventilation by starting with a conservative initial ventilator rate (For example 30 breaths per minute. This suggestion should be modified based on the clinical presentation.)ABG post resuscitation, manage ventilator to obtain goal PaO2 and PaCO2 Level of Evidence: IV- Case Series and Expert opinion based on current review of the literature.II. What parameters are recommended for FiO2 and oxygen saturations?As outlined above, hyperoxia is particularly harmful in this population. Current guidelines recommend the use of room air for the initial resuscitation of term infants. Infants resuscitated with room air have higher Apgar scores at 5 minutes, higher heart rates at 90 seconds of age, and took their first breath 30 seconds earlier than those who received 100% oxygen (4).Recommendations:Initiate resuscitation with room air (follow the Neonatal Resuscitation ProgramTM guidelines 6th edition for delivery room management)When oxygen is required, use the minimal FiO2 needed to maintain saturations > 92%Level of Evidence: IB- RCT and Expert opinion based on current review of literature.III. What defines a patient who may be a candidate for ECMO?Infants who suffer from severe HIE often meet ECMO support criteria secondary to pulmonary hypertension with or without meconium aspiration and/or hypoxic respiratory failure. Recent literature has examined the practice of continuing hypothermia therapy while undergoing ECMO with good results (5). One practice management that may be initiated as ECMO becomes likely is nitric oxide (NO). The use of NO, even at low dosing (5 ppm), can decrease the use of ECMO by as much as 35% when the oxygen index is > 25 (3). However, despite the use of NO, ECMO is often still the required therapy in this population. A recent survey to the directors of ECMO programs showed that there is significant variability in how neonates are selected for ECMO once severity of illness criteria has been met. In this survey, 48% of the responders stated they would not offer ECMO to infant’s with severe HIE (7). Recommendations:In the experience of the network sites, hypothermia may be continued safely during ECMO. Early discussion of the ECMO criteria for infants with severe HIE should be established. The discussion should include multiple disciplines (neonatology, pediatric surgery, ethics committee). Level of Evidence: IV- Case Series and Expert opinion based on current review of the literature.IV. How should temperature correction factor into the interpretation of blood gases?Hypothermia affects blood gas parameters such as pH and CO2; at lower temperatures pH increases and CO2 decreases (6). Most blood gas instruments contain a temperature-controlled sample chamber specified to be 37oC, referred to as α-stat method. In the α-stat method, uncorrected values are used to keep the pH and CO2 close to the 37oC reference value. Alternatively, in the pH-stat method, the measured pH is corrected to the actual body temperature of the patient. For example, during hypothermia (core temperature 33°C), pH will rise to 7.5 and PCO2 will decrease 34 mm Hg (6). At this point it is unclear whether the α-stat or pH-stat method should be used for the ventilator management of the asphyxiated neonate undergoing hypothermia (6). Recommendation:Recognition that blood gas values will vary depending on the method used in calibration; the clinician may consider alternative ventilator strategies to obtain goal blood gas values. Level of Evidence: V- Expert opinion based on current review of literature.V. Should patients be extubated during the cooling or rewarming process?Recommendation:Based on case reports it appears to be a safe practice if the infant meets all the parameters needed for safe extubation. These infants represent a unique population and awareness of their high-risk status must be considered: airway protection (if diminished gag reflex), seizure activity, and apnea associated with the cooling and/or rewarming processLevel of Evidence: V- Expert opinion based on current review of literature.VI. What are the recommendations regarding ventilator management?As discussed previously, initial ventilator settings should be conservative, with moderate pressures and respiratory rate.? Initial PEEP should also be conservative.? Overdistension of the lung may increase PVR and reduce venous return, therefore impairing peripheral and cerebral perfusion.? Finding the optimal balance between sufficient MAP to allow lung recruitment and its potential negative effects on circulation may often require multiple chest radiographs and echocardiography (3).?? Level of Evidence: V- Expert opinion based on current review of literature.VII. What are the recommendations regarding the use of nitric oxide (iNO)?As discussed in the section on ECMO, iNO can effectively improve oxygenation in the asphyxiated newborn, with or without evidence of PPHN.? It may also be used, even at smaller doses, to aid in the weaning of FiO2 if the patient is on high settings.? In previous studies, oxygen used has diminished after the initiation of iNO therapy.? If infants are on high FiO2 and ventilator settings consideration should be given to starting NO therapy (8). Level of Evidence: V- Expert opinion based on current review of literature.VIII. ReferencesPappas A, et al. Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy. J Pediatr 2010; 158(5):752-758.Klinger G, Beyene J, Shah P, Perlman M. Do hyperoxaemia and hypocapnia add to the risk of brain injury after intrapartum asphyxia? Arch Dis Child Fetal Neonatal Ed 2005;90:49-52.Lapointe A, and Barrington KJ. Pulmonary hypertension and the asphyxiated newborn. J Pediatr 2011; 158(2):e19-e23. Saugstad OD. Resuscitation of newborn infants: from oxygen to room air. Lancet 2010; 376:1970-1971.Massaro A, et al. Therapeutic hypothermia for neonatal encephalopathy and extracorporeal membrane oxygenation. J Pediatr 2010; 157(3):499-502.Groenendaal F, De Voogt K, van Bel F. Blood gas values during hypothermia in asphyxiated term neonates. Pediatrics 2009; 123(1):170-171.Chapman R. Patient selection for neonatal extracorporeal membrane oxygenation: beyond severity of illness. Journal of Perinatology 2009; 29: 606-611. Wessel et al. Persistent Pulmonary Hypertension of the Newborn Improved Oxygenation in a Randomized Trial of Inhaled Nitric Oxide. Pediatrics 1997. IV. Cardiovascular Support and HIESection ContentsWhat is the goal Mean Arterial Blood Pressure (MAP) for infants with HIE?What is the optimal method to manage hypotension with HIE?How does hypothermia affect hemodynamic status post asphyxia?When should an echocardiogram be obtain for infants with HIE?Should serum markers of cardiac injury be obtained in infants with HIE, whatmarkers, and when should they be obtained?How should bradycardia associated with hypothermia be managed?VII. References I. What is the goal Mean Arterial Blood Pressure (MAP) for infants with HIE?Blood pressure must remain in a safe range post HIE with the goals of avoiding hypotensive associate cerebral ischemia while ensuring the infant is not hypertensive with subsequent intra-cerebral hemorrhage. The ideal MAP for term infants with HIE has not been established. Since infants operate over a narrow blood pressure range, and hypoxic-ischemia impairs cerebral autoregulation, it is recommended to maintain MAP within the critical margin of 40mmHg to 60mmHg ADDIN EN.CITE <EndNote><Cite><Author>Volpe</Author><Year>2008</Year><RecNum>102</RecNum><record><rec-number>102</rec-number><foreign-keys><key app="EN" db-id="0e5wpxtvj2v5x4ewattvp2z4ww05zzez0svv">102</key></foreign-keys><ref-type name="Book">6</ref-type><contributors><authors><author>Volpe, JJ</author></authors><secondary-authors><author>Volpe, JJ</author></secondary-authors></contributors><titles><title>Neurology of the Newborn</title></titles><edition>Fifth</edition><section>400-480</section><dates><year>2008</year></dates><pub-location>Philadelphia</pub-location><publisher>Saunders</publisher><urls></urls></record></Cite></EndNote>(1) unless the hemodynamics suggest a more optimal MAP.Recommendations: 1. Attempt to maintain MAP between 40mmHg and 60mmHg2. Infants with pulmonary hypertension may require a MAP on the latter end of this scale3. Attempt to avoid acute fluctuations in blood pressure Level of Evidence: V- Expert opinion based on current review of literature.II. What is the optimal method to manage hypotension with HIE?There is minimal documentation regarding the ideal method to augment MAP for infants with HIE. If there is clinical or historical evidence of hypovolemia (i.e. severe anemia, placenta abruption, cord compression) than volume may be indicated. The unwarranted use of fluids may exacerbate cerebral edema ADDIN EN.CITE <EndNote><Cite><Author>Kimelberg</Author><Year>1995</Year><RecNum>160</RecNum><record><rec-number>160</rec-number><foreign-keys><key app="EN" db-id="0e5wpxtvj2v5x4ewattvp2z4ww05zzez0svv">160</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kimelberg, H. K.</author></authors></contributors><auth-address>Division of Neurosurgery, Albany Medical College, New York, USA.</auth-address><titles><title>Current concepts of brain edema. Review of laboratory investigations</title><secondary-title>J Neurosurg</secondary-title></titles><periodical><full-title>J Neurosurg</full-title></periodical><pages>1051-9</pages><volume>83</volume><number>6</number><edition>1995/12/01</edition><keywords><keyword>Amino Acids/metabolism</keyword><keyword>Animals</keyword><keyword>Astrocytes/metabolism</keyword><keyword>Brain Edema/*physiopathology</keyword><keyword>Cells/metabolism</keyword><keyword>Electrolytes/metabolism</keyword><keyword>Extracellular Space/metabolism</keyword><keyword>Neurons/metabolism</keyword></keywords><dates><year>1995</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0022-3085 (Print)
0022-3085 (Linking)</isbn><accession-num>7490620</accession-num><urls><related-urls><url>;(2). A 2002 Cochrane systemic review evaluating Dopamine for the prevention of morbidity and mortality with HIE was found to be inconclusive ADDIN EN.CITE <EndNote><Cite><Author>Hunt</Author><Year>2002</Year><RecNum>161</RecNum><record><rec-number>161</rec-number><foreign-keys><key app="EN" db-id="0e5wpxtvj2v5x4ewattvp2z4ww05zzez0svv">161</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hunt, R.</author><author>Osborn, D.</author></authors></contributors><auth-address>Neonatal Neurology, Royal Women's and Royal Children's Hospitals, Melbourne, Level 2, Royal Children's Hospital, Flemington Road, Parkville, VIC, Australia, 3052. huntr@cryptic.rch.unimelb.edu.au</auth-address><titles><title>Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia</title><secondary-title>Cochrane Database Syst Rev</secondary-title></titles><periodical><full-title>Cochrane Database Syst Rev</full-title></periodical><pages>CD003484</pages><number>3</number><edition>2002/07/26</edition><keywords><keyword>Asphyxia Neonatorum/*prevention & control</keyword><keyword>Cardiotonic Agents/*therapeutic use</keyword><keyword>Dopamine/*therapeutic use</keyword><keyword>Humans</keyword><keyword>Infant, Newborn</keyword><keyword>Randomized Controlled Trials as Topic</keyword></keywords><dates><year>2002</year></dates><isbn>1469-493X (Electronic)
1361-6137 (Linking)</isbn><accession-num>12137696</accession-num><urls><related-urls><url> [pii]
10.1002/14651858.CD003484</electronic-resource-num><language>eng</language></record></Cite></EndNote>(3). Further, Dopamine may not be the ideal first line agent for infants with evidence of pulmonary hypertension (PPHN) and HIE because it increases both systemic (SVR) and pulmonary vascular resistance (PVR) ADDIN EN.CITE <EndNote><Cite><Author>Cheung</Author><Year>2001</Year><RecNum>162</RecNum><record><rec-number>162</rec-number><foreign-keys><key app="EN" db-id="0e5wpxtvj2v5x4ewattvp2z4ww05zzez0svv">162</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheung, P. Y.</author><author>Barrington, K. J.</author></authors></contributors><auth-address>McGill University, Montreal, Quebec, Canada.</auth-address><titles><title>The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets</title><secondary-title>Crit Care</secondary-title></titles><periodical><full-title>Crit Care</full-title></periodical><pages>158-66</pages><volume>5</volume><number>3</number><edition>2001/05/17</edition><keywords><keyword>Animals</keyword><keyword>Animals, Newborn</keyword><keyword>Anoxia/chemically induced/*drug therapy/physiopathology</keyword><keyword>Cardiotonic Agents/administration & dosage/*pharmacology/therapeutic use</keyword><keyword>Disease Models, Animal</keyword><keyword>Dopamine/administration & dosage/*pharmacology/therapeutic use</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Epinephrine/administration & dosage/*pharmacology/therapeutic use</keyword><keyword>Fentanyl/diagnostic use</keyword><keyword>Hemodynamics/*drug effects</keyword><keyword>Liver Circulation/drug effects</keyword><keyword>Oxygen/*blood</keyword><keyword>Oxygen Consumption/drug effects</keyword><keyword>Pulmonary Circulation/drug effects</keyword><keyword>Random Allocation</keyword><keyword>Splanchnic Circulation/drug effects</keyword><keyword>Swine</keyword></keywords><dates><year>2001</year></dates><isbn>1364-8535 (Print)
1364-8535 (Linking)</isbn><accession-num>11353933</accession-num><urls><related-urls><url>;(4). Dobutamine, at high doses, can also increase pulmonary artery pressure while reducing afterload and therefore would not be an ideal agent for infants with HIE and PPHN ADDIN EN.CITE <EndNote><Cite><Author>Cheung</Author><Year>1999</Year><RecNum>163</RecNum><record><rec-number>163</rec-number><foreign-keys><key app="EN" db-id="0e5wpxtvj2v5x4ewattvp2z4ww05zzez0svv">163</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheung, P. Y.</author><author>Barrington, K. J.</author><author>Bigam, D.</author></authors></contributors><auth-address>Department of Pediatrics, University of Alberta, Edmonton, Canada.</auth-address><titles><title>The hemodynamic effects of dobutamine infusion in the chronically instrumented newborn piglet</title><secondary-title>Crit Care Med</secondary-title></titles><periodical><full-title>Crit Care Med</full-title></periodical><pages>558-64</pages><volume>27</volume><number>3</number><edition>1999/04/13</edition><keywords><keyword>Analysis of Variance</keyword><keyword>Animals</keyword><keyword>Animals, Newborn</keyword><keyword>Cardiotonic Agents/administration & dosage/*pharmacology</keyword><keyword>Dobutamine/administration & dosage/*pharmacology</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Hemodynamics/*drug effects</keyword><keyword>Infusions, Intravenous</keyword><keyword>Random Allocation</keyword><keyword>Renal Circulation/drug effects</keyword><keyword>Swine</keyword><keyword>Thermodilution</keyword></keywords><dates><year>1999</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0090-3493 (Print)
0090-3493 (Linking)</isbn><accession-num>10199537</accession-num><urls><related-urls><url>;(5).Epinephrine, at low to moderate dosing, will increase SVR with little effect on PVR. In addition, epinephrine can improve myocardial perfusion and dysfunction. Infants with HIE and PPHN, epinephrine may be the optimal choice for blood pressure augmentation ADDIN EN.CITE <EndNote><Cite><Author>Cheung</Author><Year>2001</Year><RecNum>162</RecNum><record><rec-number>162</rec-number><foreign-keys><key app="EN" db-id="0e5wpxtvj2v5x4ewattvp2z4ww05zzez0svv">162</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheung, P. Y.</author><author>Barrington, K. J.</author></authors></contributors><auth-address>McGill University, Montreal, Quebec, Canada.</auth-address><titles><title>The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets</title><secondary-title>Crit Care</secondary-title></titles><periodical><full-title>Crit Care</full-title></periodical><pages>158-66</pages><volume>5</volume><number>3</number><edition>2001/05/17</edition><keywords><keyword>Animals</keyword><keyword>Animals, Newborn</keyword><keyword>Anoxia/chemically induced/*drug therapy/physiopathology</keyword><keyword>Cardiotonic Agents/administration & dosage/*pharmacology/therapeutic use</keyword><keyword>Disease Models, Animal</keyword><keyword>Dopamine/administration & dosage/*pharmacology/therapeutic use</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Epinephrine/administration & dosage/*pharmacology/therapeutic use</keyword><keyword>Fentanyl/diagnostic use</keyword><keyword>Hemodynamics/*drug effects</keyword><keyword>Liver Circulation/drug effects</keyword><keyword>Oxygen/*blood</keyword><keyword>Oxygen Consumption/drug effects</keyword><keyword>Pulmonary Circulation/drug effects</keyword><keyword>Random Allocation</keyword><keyword>Splanchnic Circulation/drug effects</keyword><keyword>Swine</keyword></keywords><dates><year>2001</year></dates><isbn>1364-8535 (Print)
1364-8535 (Linking)</isbn><accession-num>11353933</accession-num><urls><related-urls><url>;(4). Milrinone increases myocardial contractility and acts as a vasodilator (systemic and pulmonary). Infants with myocardial dysfunction, Milrinone may be a superior agent to improve contractility ensuring MAP is within target range prior to its initiation PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NY05hbWFyYTwvQXV0aG9yPjxZZWFyPjIwMDY8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NY05hbWFyYTwvQXV0aG9yPjxZZWFyPjIwMDY8L1llYXI+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ADDIN EN.CITE.DATA (6, 7). Recommendations: 1. If infant is hypotensive, start treatment with a pressor which supports the clinical need of the neonate. 2. Obtain an Echocardiogram to assist in management. If myocardial dysfunction is evident on echocardiogram, consider the addition of epinephrine. 3. This is the recommended approach for hypotensive, encephalopathic infants with or without PPHN. Of note, the addition of Milrinone as a single agent may be beneficial in PPHN when normotensive or a combination of Milrinone with low dose epinephrine to prevent systemic hypotension with Milrinone infusion or if the patient had hypotension and PPHN PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NY05hbWFyYTwvQXV0aG9yPjxZZWFyPjIwMDY8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NY05hbWFyYTwvQXV0aG9yPjxZZWFyPjIwMDY8L1llYXI+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ADDIN EN.CITE.DATA (6, 7).4. In the case of refractory hypotension to pressor support, consideration should be given to the addition of steroids. Level of Evidence: IV- Case Series and Expert opinion based on current review of the literature.III. How does hypothermia affect hemodynamic status post asphyxia?Mild systemic hypothermia in itself appears to have minimal clinical effects on hemodynamic status. The CoolCap Trial which utilized mild systemic hypothermia to a rectal temperature of 34.5°C did not demonstrate affects on arterial blood pressure or initial treatment with inotropes or volume in infants with moderate to severe HIE ADDIN EN.CITE <EndNote><Cite><Author>Battin</Author><Year>2009</Year><RecNum>166</RecNum><record><rec-number>166</rec-number><foreign-keys><key app="EN" db-id="0e5wpxtvj2v5x4ewattvp2z4ww05zzez0svv">166</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Battin, M. R.</author><author>Thoresen, M.</author><author>Robinson, E.</author><author>Polin, R. A.</author><author>Edwards, A. D.</author><author>Gunn, A. J.</author></authors></contributors><auth-address>Newborn Services, National Women's Health, Auckland City Hospital, Private Bag 92 024, Auckland, New Zealand. malcolmb@t.nz</auth-address><titles><title>Does head cooling with mild systemic hypothermia affect requirement for blood pressure support?</title><secondary-title>Pediatrics</secondary-title></titles><periodical><full-title>Pediatrics</full-title></periodical><pages>1031-6</pages><volume>123</volume><number>3</number><edition>2009/03/04</edition><keywords><keyword>Blood Pressure/*physiology</keyword><keyword>Electroencephalography</keyword><keyword>Female</keyword><keyword>Fluid Therapy</keyword><keyword>*Head</keyword><keyword>Heart Rate/*physiology</keyword><keyword>Homeostasis</keyword><keyword>Humans</keyword><keyword>Hypothermia, Induced/*methods</keyword><keyword>Hypoxia-Ischemia, Brain/physiopathology/*therapy</keyword><keyword>Infant, Newborn</keyword><keyword>Male</keyword><keyword>Monitoring, Physiologic</keyword><keyword>Rewarming</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1098-4275 (Electronic)
0031-4005 (Linking)</isbn><accession-num>19255036</accession-num><urls><related-urls><url> [pii]
10.1542/peds.2008-1610</electronic-resource-num><language>eng</language></record></Cite></EndNote>(8). In the NICHD whole body hypothermia trial, there were no differences in the incidence of pulmonary hypertension or cardiac arrhythmias between the treatment and controlled groups. However, there was a trend towards an increase use of inotropes in the hypothermia group PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaGFua2FyYW48L0F1dGhvcj48WWVhcj4yMDA1PC9ZZWFy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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaGFua2FyYW48L0F1dGhvcj48WWVhcj4yMDA1PC9ZZWFy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ADDIN EN.CITE.DATA (9). In addition, the TOBY Trial did not find any significant difference in the incidence of hypotension, cardiac arrhythmias or pulmonary hypertension between hypothermic and normothermic infants PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BenpvcGFyZGk8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFy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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BenpvcGFyZGk8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFy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ADDIN EN.CITE.DATA (10).Level of Evidence: IA- Based on Randomized Controlled Trials. VI. When should an echocardiogram be obtain for infants with HIE?We recommend an Echocardiogram be performed in any infant with HIE. Echocardiogram may be repeated and used to guide therapy in the following clinical scenarios:1. Elevated cardiac enzymes if performed at your center2. Clinical evidence of cardiac dysfunction3. Clinical evidence of pulmonary hypertension4. Hypotension (MAP < 40mmHg)5. Requiring inotropic support Level of Evidence: V- Expert opinion based on current review of literature.V. Should serum markers of cardiac injury be obtained in infants with HIE, what markers, and when should they be obtained?Myocardial dysfunction is often the direct cause of perinatal brain injury. Myocardial damage may be clinically occult with mild HIE or manifest as a systemic hypoperfusion state in the cases of moderate to severe HIE. Serum cardiac markers may assist in injury detection and guide clinical management. Recent evidence suggests cardiac Troponins are superior to other markers of myocardial injury (LDH, CK, CK-MB) in detecting earlier, cardiac specific injury PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HdW5lczwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+PFJl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==
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HdW5lczwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+PFJl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==
ADDIN EN.CITE.DATA (11, 12). Cardiac Troponin T (cTnT), is a structural cytoplasmic protein of myosites and the most cardiac specific of the troponins in the neonatal period ADDIN EN.CITE <EndNote><Cite><Author>El-Khuffash</Author><Year>2008</Year><RecNum>170</RecNum><record><rec-number>170</rec-number><foreign-keys><key app="EN" db-id="0e5wpxtvj2v5x4ewattvp2z4ww05zzez0svv">170</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>El-Khuffash, A. F.</author><author>Molloy, E. J.</author></authors></contributors><auth-address>Department of Neonatology, National Maternity Hospital, Dublin, Ireland. afif_faisal@</auth-address><titles><title>Serum troponin in neonatal intensive care</title><secondary-title>Neonatology</secondary-title></titles><periodical><full-title>Neonatology</full-title></periodical><pages>1-7</pages><volume>94</volume><number>1</number><edition>2007/12/22</edition><keywords><keyword>Asphyxia Neonatorum/blood/physiopathology</keyword><keyword>Biological Markers/blood</keyword><keyword>Cardiomyopathies/blood/*physiopathology</keyword><keyword>Echocardiography</keyword><keyword>Humans</keyword><keyword>Infant, Newborn</keyword><keyword>*Intensive Care, Neonatal</keyword><keyword>Respiratory Distress Syndrome, Newborn/blood/physiopathology</keyword><keyword>Troponin/*blood</keyword></keywords><dates><year>2008</year></dates><isbn>1661-7819 (Electronic)
1661-7800 (Linking)</isbn><accession-num>18097151</accession-num><urls><related-urls><url> [pii]
10.1159/000112540</electronic-resource-num><language>eng</language></record></Cite></EndNote>(13). Further, there is only one commercially available assay for Troponin T making standardization between different studies and reference ranges relatively consistent. Although there is not an accepted normal range for cTnT in neonates, a value of ≥ 0.1 ng/ml in the setting of HIE has been considered as elevated in several studies and as a potential indicator of mortality in the neonatal period PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYXR0ZXI8L0F1dGhvcj48UmVjTnVtPjE3MTwvUmVjTnVt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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYXR0ZXI8L0F1dGhvcj48UmVjTnVtPjE3MTwvUmVjTnVt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ADDIN EN.CITE.DATA (11-14). Recommendations:1. If performed at your center and clinically indicated, obtain an ECG and Echocardiogram if cTnT is ≥ 0.1ng/ml to evaluate myocardial ischemia and cardiac function.As stated above, Cardiac Troponin T may also be predictive of outcome and may aid the bedside clinician with additional prognostic information. Level of Evidence: IIC- based on outcome data and case-controlled studies. VI. How should bradycardia associated with hypothermia be managed? Relative bradycardia (70-100 bpm) is not an uncommon occurrence in infants undergoing hypothermia. However, pathologic bradycardia can be a result of cardiac dysfunction, arrhythmias, deep hypothermia and increased intracranial pressure. Clinical intervention should be initiated when bradycardia is associated with evidence of decreased cardiac output, electrolyte abnormalities, elevated cardiac enzymes, and/or ECG abnormalities. Recommendations:1. If heart rate is <70bpm with evidence of reduced cardiac output (worsening metabolic acidosis, ↑lactic acid, prolonged capillary refill time, diminished pulses, low or borderline low MAP) obtain electrolytes including ionized calcium, ECG, echocardiogram, and ensure core temperature is appropriate.2. If heart rate is <70bpm but >60bpm without evidence of reduced cardiac output, normal electrolytes, normal ECG and echocardiogram then close clinical observation is a reasonable approach. Level of Evidence: V- Expert opinion based on current review of literature.VII. References: ADDIN EN.REFLIST 1. Volpe J. Neurology of the Newborn. Fifth ed. Philadelphia: Saunders; 2008.2. Kimelberg HK. Current concepts of brain edema. Review of laboratory investigations. J Neurosurg 1995;83(6):1051-9.3. Hunt R, Osborn D. Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia. Cochrane Database Syst Rev 2002(3):CD003484.4. Cheung PY, Barrington KJ. The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets. Crit Care 2001;5(3):158-66.5. Cheung PY, Barrington KJ, Bigam D. The hemodynamic effects of dobutamine infusion in the chronically instrumented newborn piglet. Crit Care Med 1999;27(3):558-64.6. McNamara PJ, Laique F, Muang-In S, Whyte HE. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 2006;21(2):217-22.7. Bassler D, Choong K, McNamara P, Kirpalani H. Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 2006;89(1):1-5.8. Battin MR, Thoresen M, Robinson E, Polin RA, Edwards AD, Gunn AJ. Does head cooling with mild systemic hypothermia affect requirement for blood pressure support? Pediatrics 2009;123(3):1031-6.9. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005;353(15):1574-84.10. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009;361(14):1349-58.11. Gunes T, Ozturk MA, Koklu SM, Narin N, Koklu E. Troponin-T levels in perinatally asphyxiated infants during the first 15 days of life. Acta Paediatr 2005;94(11):1638-43.12. Boo NY, Hafidz H, Nawawi HM, Cheah FC, Fadzil YJ, Abdul-Aziz BB, et al. Comparison of serum cardiac troponin T and creatine kinase MB isoenzyme mass concentrations in asphyxiated term infants during the first 48 h of life. J Paediatr Child Health 2005;41(7):331-7.13. El-Khuffash AF, Molloy EJ. Serum troponin in neonatal intensive care. Neonatology 2008;94(1):1-7.14. Matter M, Abdel-Hady H, Attia G, Hafez M, Seliem W, Al-Arman M. Myocardial performance in asphyxiated full-term infants assessed by Doppler tissue imaging. Pediatr Cardiol;31(5):634-42.V. Neurologic and Seizure ManagementSection ContentsWhat medications should be used for analgesia during hypothermia?When and how should infants be monitored for seizures?How should seizures be managed in neonates with HIE?What is the optimal time for neuroimaging in neonates with HIE?ReferencesI. What medications should be used for analgesia during hypothermia?Though optimal therapy for sedation in neonates is a highly debated topic, neonates being cooled do demonstrate agitation and irritability in response to cooling. Studies of animal models of global hypoxic insults demonstrate that unsedated piglets subjected to hypothermia post hypoxic injury do not benefit from total body cooling and have grossly elevated cortisol levels, shivering, and generally increased motor activity that is postulated to diminish and even counteract the neuroprotective benefits of total body hypothermia (12). Due to known suppression of the cytochrome P450 pathway due to cooling as well as the risk for polypharmacy and drug interactions in acutely ill neonates, care must be taken in choosing a medication for analgesia (13).Recommendations:Begin an opiate upon initiation of cooling.Stop unnecessary analgesia and sedation after warming has occurred. If opiate at low dosages does not provide adequate analgesia, the dose can be gradually increased as well as having other medications may be added. The goal should be continuous and adequate analgesia and anxiolysis to prevent excessive irritability and agitation and not an attempt to maintain the infant on mechanical ventilation, unless clinically indicated.Level of Evidence: V Expert opinion based on current review of the literature and animal models.II. When and how should infants be monitored for seizures?Multiple studies have shown the benefit of continuous EEG monitoring of neonates with HIE. Besides being a very useful early predictor of neurologic outcomes(1,2), studies have shown that aggressive treatment of seizures decreases neurologic sequlae (3). Due to the large amount of resources consumed by continuous EEG monitoring, amplitude integrated EEG has been used extensively for neonates with HIE for monitoring. The ease of application and interpretation of aEEG makes it especially useful in continuous monitoring.Recommendations:Upon admission to the NICU, neonates suspected of having HIE should have an aEEG placed (see #3).Monitoring duration via aEEG should optimally occur during the entire systemic hypothermia process, including warming.If video EEG is used for continuous monitoring instead of aEEG, someone at the bedside of the patient should be trained in interpretation of the EEG or the aEEG feature on the video EEG should be monitored by the bedside personnel.If aEEG demonstrates seizure activity and/or an abnormal background pattern, it is recommended to obtain formal EEG evaluation and continuously monitor for electrographic seizures until warming has occurred and seizures are under control (2).Level of Evidence: IIC based on outcome data and case control studiesIII. How should seizures be managed in neonates with HIE?HIE is the number one cause of neonatal seizures. Despite the high incidence of seizures in this population of neonates, a Cochrane review did not find benefit in morbidity and mortality with routine use of prophylactic anti-epileptic medications (4).Though there is no evidence to support routine prophylaxis, studies have shown a definite benefit to aggressive therapy of seizures: clinical or electrographic. FDA approved management for seizures in neonates is limited to Phenobarbital and Fosphenytoin or Phenytoin. Studies have not demonstrated a benefit of Phenobarbital over Phenytoin (5). Recent randomized control studies have demonstrated that Keppra is a safe and effective therapy in neonatal seizures with vastly better pharmacokinetics and side effect profile than Phenobarbital and Phenytoin (6,7,8). Some studies have also demonstrated a potential neuroprotective benefit of Keppra and neurotoxic side effects associated with Phenobarbital and Phenytoin (9).Recommendations:Any electrographic or clinical evidence of seizures should be aggressively treated with appropriate anti-epileptic therapy and close monitoring for recurrence as over 50% of seizures from HIE will require more than one medication for treatment.Initial treatment may be with either an intravenous benzodiazepine or IV Phenobarbital at 20 mg/kg.Maintenance treatment should be started in all neonates with seizures and continued until a week after warming. A week after warming, the need for continued anti-epileptics should be discussed by the primary care team in conjunction with neurology and guided by each individual situation (5).VI. What is the optimal time for neuroimaging in neonates with HIE?Appropriate neuroimaging is an important part of evaluating the etiology of HIE and predicting long term neurodevelopemental outcomes. Magnetic Resonance Imaging with diffusion weighted images and spectroscopy of the basal ganglia is the imaging study of choice (10). Elevated lactate peaks and low N-acetylaspartate levels in the basal ganglia are associated with poor neurodevelopemental outcomes (10, 11). Deep gray matter injuries including basal ganglia injuries and thalamic injury can indicate acute injury while injuries in the watershed areas can indicate prolonged partial hypoxia (5).Recommendations:Head ultrasound should be acquired on admission.MRI with diffusion weighted images and spectroscopy of the basal ganglia is the preferred study.Suggested MRI imaging can be performed at 4-5 days of life and again at 7-12 days. If only one MRI can be performed, it should occur during the 7-12 day period. These recommendations may need to be adjusted in critically ill neonates who will be compromised in obtaining the MRI.Level of Evidence: IA randomized control trials.V. References1. Pressler RM, Boylan GB, Morton M, et al.: Early serial EEG in hypoxic ischaemic encephalopathy. Clinical Neurophysiology 2001; 112:31–37.2. de Vries LS, Toet MC: Amplitude integrated electroencephalography in the full-term newborn. Clinical Perinatology 2006; 33:619–632.3. van Rooij L, Toet MC, et al.: Effect of Treatment of Subclinical Neonatal Seizures Detected With aEEG: Randomized, Controlled Trial Pediatrics 2010; 125:358-366.4. Evans DJ, Levene MI.: Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database; 2007; Jul 18;(3):CD001240.5. Glass HC, Ferriero DM: Treatment of Hypoxic-Ischemic Encephalopathy in Newborns. Current Treatment Options in Neurology 2007;9 :414–423.6. Abend, et al. Levetiracetam for Treatment of Neonatal Seizures. Journal of Child Neurology 2011; 26:465-470.7. Khan, et al.: Use of Intravenous Levetiracetam for Management of Acute Seizures in Neonates. Pediatric Neurology 2011;44:265-269.8. Ramantani, et al.: Levetiracetam: Safety and Efficacy in Neonatal Seizures. European Journal of Paediatric Neurology 2011;15: 1-7.9. Cilio, Ferriero.: Synergistic Neuroprotective Therapies with Hypothermia. Seminars in Fetal & Neonatal Medicine 2010;15: 293-298.10. Boichot, Walker, Durand, et al.: Term neonate prognoses after perinatal asphyxia: contributions of MR imaging, MR spectroscopy, relaxation times, and apparent diffusion coefficients. Radiology 2006; 239:839–848.11. Barkovich, Miller, Bartha, et al.: MR imaging,MR spectroscopy, and diffusion tensor imaging ofsequential studies in neonates with encephalopathy. American Journal of Neuroradiology 2006; 27:533–547.12. Thoresen, Satas, Loberg, et al.: Twenty-four hours of mild hypothermia in unsedated newborn pigs starting after a severe global hypoxic-ischemic insult is not neuroprotective. Pediatric Research. 2001;50 (3):405– 411.13. Tortorici, Kochanek, Polovac: Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Critical Care Medicine 2007; Sep; 35(9):2196-204. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
Related searches
- university of florida graduate certificate
- university of florida certification programs
- university of florida online certifications
- university of florida salary database
- university of florida softball camp
- university of florida 2020 roster
- university of florida hospital north
- university of florida ceeb code
- university of florida online biology
- university of florida biology ranking
- university of florida marine science
- university of florida marine biology